A61K36/33

Cactus mucilage and ferric ions for the removal of arsenate (As(V)) from water

Potable drinking water is plagued with widespread arsenic contamination, particularly in developing communities. Ferric ions were introduced to interact with arsenate based on the strong affinity of arsenate for ferric hydroxides, followed by mucilage addition. The mucilage coagulated and flocculated the ferric-arsenate complex and formed visible flocs that settled at the bottom of the tubes. The system showed 75-96% arsenate removal in 1 hour, while longer retention times showed 100% removal. The role of the mucilage was demonstrated by untreated solutions showing no concentration difference and remaining stable for more than 15 days. This mucilage-based technology has the potential to be a relatively inexpensive, environmentally sustainable alternative to synthetic polymer flocculants for removing arsenic from drinking water.

WEIGHT MANAGEMENT SYSTEMS AND RELATED METHODS

Systems and methods of weight management and compositions or formulations useful therein are disclosed and described.

WEIGHT MANAGEMENT SYSTEMS AND RELATED METHODS

Systems and methods of weight management and compositions or formulations useful therein are disclosed and described.

WEIGHT MANAGEMENT SYSTEMS AND RELATED METHODS

Systems and methods of weight management and compositions or formulations useful therein are disclosed and described.

METERED DOSING COMPOSITIONS AND METHODS OF USE OF PSYCHEDELIC COMPOUNDS

New metered-dosing compositions and methods of use comprising at least one psychedelic compound derived from living organisms such as plants and fungi, synthetically-derived forms or synthetic analogue. The composition for use in metered-dosing administration modalities, including a nasal spray, pressurized metered-dose inhaler, etc.

METERED DOSING COMPOSITIONS AND METHODS OF USE OF PSYCHEDELIC COMPOUNDS

New metered-dosing compositions and methods of use comprising at least one psychedelic compound derived from living organisms such as plants and fungi, synthetically-derived forms or synthetic analogue. The composition for use in metered-dosing administration modalities, including a nasal spray, pressurized metered-dose inhaler, etc.

NATURAL EXTRACTS FOR MODULATING PP2A METHYLATION, AND PROVIDING ANTIOXIDANT AND ANTI INFLAMMATORY ACTIVITY

Compositions containing natural and botanical extracts for use in inhibiting one, two, or three of (a)-(c): (a) demethylation of PP2A by PME-1 methylesterase; (b) formation of free radicals and reactive oxygen species; and/or (c) inflammation. These compositions include an extract of one or more botanicals selected from the group consisting of: juniper berry fruit, schisandra fruit, strawberry fruit, avocado seeds, black raspberry seeds, blueberry seeds, celery seeds, cranberry seeds, fennel seeds, grape seeds, guarana seeds, red raspberry seeds, maca root, goldenseal root, turmeric root, magnolia bark, pygeum bark, red raspberry leaf, almond, cocoa powder, Echinacea angustifolia, prickly pear cactus and walnut.

NATURAL EXTRACTS FOR MODULATING PP2A METHYLATION, AND PROVIDING ANTIOXIDANT AND ANTI INFLAMMATORY ACTIVITY

Compositions containing natural and botanical extracts for use in inhibiting one, two, or three of (a)-(c): (a) demethylation of PP2A by PME-1 methylesterase; (b) formation of free radicals and reactive oxygen species; and/or (c) inflammation. These compositions include an extract of one or more botanicals selected from the group consisting of: juniper berry fruit, schisandra fruit, strawberry fruit, avocado seeds, black raspberry seeds, blueberry seeds, celery seeds, cranberry seeds, fennel seeds, grape seeds, guarana seeds, red raspberry seeds, maca root, goldenseal root, turmeric root, magnolia bark, pygeum bark, red raspberry leaf, almond, cocoa powder, Echinacea angustifolia, prickly pear cactus and walnut.

NATURAL EXTRACTS FOR MODULATING PP2A METHYLATION, AND PROVIDING ANTIOXIDANT AND ANTI INFLAMMATORY ACTIVITY

Compositions containing natural and botanical extracts for use in inhibiting one, two, or three of (a)-(c): (a) demethylation of PP2A by PME-1 methylesterase; (b) formation of free radicals and reactive oxygen species; and/or (c) inflammation. These compositions include an extract of one or more botanicals selected from the group consisting of: juniper berry fruit, schisandra fruit, strawberry fruit, avocado seeds, black raspberry seeds, blueberry seeds, celery seeds, cranberry seeds, fennel seeds, grape seeds, guarana seeds, red raspberry seeds, maca root, goldenseal root, turmeric root, magnolia bark, pygeum bark, red raspberry leaf, almond, cocoa powder, Echinacea angustifolia, prickly pear cactus and walnut.

COSMETIC COMPOSITIONS AND USES THEREOF

A method of treating skin is disclosed. The method can include topically applying to skin in need thereof a composition comprising Hylocereus undatus fruit extract, Aloe barbadensis leaf extract, and methyldihydrojasmonate or panthenol, wherein topical application of the composition treats the skin.